Tundi, Prince Cary .

HRN: 07-05-19  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/19/2026
CEFUROXIME 1.5GM (VIAL)
06/19/2026
06/26/2026
IV
1.5 Gm
Q8h
S/P Removal Of Implant
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: